Literature DB >> 2641451

Gallium-67 citrate imaging for the assessment of radiation pneumonitis.

M Kataoka1.   

Abstract

In order to evaluate its usefulness in the assessment of radiation pneumonitis, gallium-67 citrate (67Ga) imaging was performed before and after radiation therapy (RT) on 103 patients with lung cancer. In 23 patients with radiation pneumonitis detected radiographically, abnormal 67Ga uptake in sites other than tumors was found in all post-RT 67Ga lung images. Three patterns of uptake were found: (A), focal uptake corresponding to the RT field (n = 10); (B), diffuse uptake including the RT field (n = 4), and (C), diffuse uptake outside the RT field (n = 9). The area of 67Ga uptake was consistent with that of interstitial pneumonitis as revealed histopathologically in 7 cases. 67Ga uptake in pattern (C) was an indicator of poor prognosis for the patients with radiation pneumonitis. 67Ga uptake in the patients with reversible pneumonitis disappeared with steroid therapy. Sixteen (20%) of 80 asymptomatic patients, in whose chest radiographs there was no finding of radiation pneumonitis, showed transient 67Ga uptake. These were considered to occur in the subclinical radiation pneumonitis. These data suggest that 67Ga imaging is more sensitive than chest radiography in the detection of radiation pneumonitis and is useful in the assessment of the extent and clinical course of radiation pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2641451     DOI: 10.1007/bf03164588

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  33 in total

1.  Hyperacute radiation pneumonitis.

Authors:  A L Goldman; R Enquist
Journal:  Chest       Date:  1975-05       Impact factor: 9.410

2.  THE ACUTE RADIATION PNEUMONITIS SYNDROME.

Authors:  J A HOLT
Journal:  J Coll Radiol Australas       Date:  1964-02

3.  Radiation pneumonitis.

Authors:  J C SMITH
Journal:  Am Rev Respir Dis       Date:  1963-05

4.  Gallium 67 citrate scanning in patients with pulmonary sarcoidosis.

Authors:  A Heshiki; S L Schatz; K A McKusick; D W Bowersox; J S Soin; H N Wagner
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-12

5.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

6.  Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide.

Authors:  C W Trask; T Joannides; P G Harper; J S Tobias; S G Spiro; D M Geddes; R L Souhami; P C Beverly
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

7.  Hypersensitivity to procarbazine (Matulane) manifested by fever and pleuropulmonary reaction.

Authors:  S E Jones; M Moore; N Blank; R A Castellino
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

8.  Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.

Authors:  P Alberto; K W Brunner; G Martz; J Obrecht; R W Sonntag
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

9.  CT appearance of acute radiation-induced injury in the lung.

Authors:  J Ikezoe; S Takashima; S Morimoto; K Kadowaki; N Takeuchi; T Yamamoto; K Nakanishi; M Isaza; J Arisawa; H Ikeda
Journal:  AJR Am J Roentgenol       Date:  1988-04       Impact factor: 3.959

10.  Role of gallium 67 in inflammatory disease.

Authors:  E V Staab; W H McCartney
Journal:  Semin Nucl Med       Date:  1978-07       Impact factor: 4.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.